MedPath
FDA Approval

Eptifibatide

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
USV Private Limited
DUNS: 650611585
Effective Date
March 26, 2019
Labeling Type
Human Prescription Drug Label
Eptifibatide(2 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

USV Private Limited

USV Private Limited

650434348

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Eptifibatide

Product Details

NDC Product Code
62147-0600
Application Number
ANDA204362
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
March 18, 2019
Code: NA8320J834Class: ACTIBQuantity: 2 mg in 1 mL
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACTQuantity: 5.25 mg in 1 mL
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath